Trial intelligence / Profile preview

Perioperative Progesterone in Brain Tumors

NCT04414020Phase 1Unknown

Sponsor
Minia University
Start
Jun 2020
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of progesterone in cerebral edema and neuronal injury (2 arms), sponsored by Minia University. Primary endpoint: Number of Participants With craniotomy-Related Adverse Events at 3 months. Status: unknown.

02

Drugs

progesterone
03

Conditions

cerebral edemaneuronal injury

Beyond the preview

Go deeper on NCT04414020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04414020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call